Zevra Therapeutics Stock Forward View - Accumulation Distribution
| ZVRA Stock | 8.50 0.10 1.19% |
Zevra Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Zevra Therapeutics stock prices and determine the direction of Zevra Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Zevra Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the rsi of Zevra Therapeutics' share price is below 20 . This usually means that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.01) | EPS Estimate Current Year 1.16 | EPS Estimate Next Year 0.62 | Wall Street Target Price 22.5438 | EPS Estimate Current Quarter (0.02) |
Using Zevra Therapeutics hype-based prediction, you can estimate the value of Zevra Therapeutics from the perspective of Zevra Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Zevra Therapeutics using Zevra Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Zevra using crowd psychology based on the activity and movement of Zevra Therapeutics' stock price.
Zevra Therapeutics Short Interest
A significant increase or decrease in Zevra Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Zevra. Short interest can provide insight into the potential direction of Zevra Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 9.3546 | Short Percent 0.0857 | Short Ratio 4.58 | Shares Short Prior Month 4 M | 50 Day MA 8.6628 |
Zevra Relative Strength Index
Zevra Therapeutics Hype to Price Pattern
Investor biases related to Zevra Therapeutics' public news can be used to forecast risks associated with an investment in Zevra. The trend in average sentiment can be used to explain how an investor holding Zevra can time the market purely based on public headlines and social activities around Zevra Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Zevra Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Zevra Therapeutics.
Zevra Therapeutics Implied Volatility | 1.35 |
Zevra Therapeutics' implied volatility exposes the market's sentiment of Zevra Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Zevra Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Zevra Therapeutics stock will not fluctuate a lot when Zevra Therapeutics' options are near their expiration.
Zevra Therapeutics after-hype prediction price | USD 8.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Zevra Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Zevra contract
Based on the Rule 16, the options market is currently suggesting that Zevra Therapeutics will have an average daily up or down price movement of about 0.0844% per day over the life of the 2026-05-15 option contract. With Zevra Therapeutics trading at USD 8.5, that is roughly USD 0.007172 . If you think that the market is fully incorporating Zevra Therapeutics' daily price movement you should consider acquiring Zevra Therapeutics options at the current volatility level of 1.35%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Zevra Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Zevra Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Zevra Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Zevra Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Zevra Therapeutics' open interest, investors have to compare it to Zevra Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Zevra Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Zevra. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Zevra Therapeutics Additional Predictive Modules
Most predictive techniques to examine Zevra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zevra using various technical indicators. When you analyze Zevra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 13876.21 | 0.0287 |
| Check Zevra Therapeutics Volatility | Backtest Zevra Therapeutics | Information Ratio |
Zevra Therapeutics Trading Date Momentum
| On February 16 2026 Zevra Therapeutics was traded for 8.50 at the closing time. The top price for the day was 8.70 and the lowest listed price was 8.45 . There was no trading activity during the period 0.0. Lack of trading volume on February 16, 2026 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 0.47% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Zevra Therapeutics to competition |
Other Forecasting Options for Zevra Therapeutics
For every potential investor in Zevra, whether a beginner or expert, Zevra Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zevra Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zevra. Basic forecasting techniques help filter out the noise by identifying Zevra Therapeutics' price trends.Zevra Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zevra Therapeutics stock to make a market-neutral strategy. Peer analysis of Zevra Therapeutics could also be used in its relative valuation, which is a method of valuing Zevra Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Zevra Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Zevra Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zevra Therapeutics shares will generate the highest return on investment. By undertsting and applying Zevra Therapeutics stock market strength indicators, traders can identify Zevra Therapeutics entry and exit signals to maximize returns.
Zevra Therapeutics Risk Indicators
The analysis of Zevra Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zevra Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zevra stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.97 | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Zevra Therapeutics
The number of cover stories for Zevra Therapeutics depends on current market conditions and Zevra Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zevra Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zevra Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Zevra Therapeutics Short Properties
Zevra Therapeutics' future price predictability will typically decrease when Zevra Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zevra Therapeutics often depends not only on the future outlook of the potential Zevra Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zevra Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.3 M | |
| Cash And Short Term Investments | 69.5 M |
Check out Historical Fundamental Analysis of Zevra Therapeutics to cross-verify your projections. For information on how to trade Zevra Stock refer to our How to Trade Zevra Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zevra Therapeutics. Anticipated expansion of Zevra directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zevra Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.47 | Revenue Per Share | Quarterly Revenue Growth 6.054 | Return On Assets | Return On Equity |
Understanding Zevra Therapeutics requires distinguishing between market price and book value, where the latter reflects Zevra's accounting equity. The concept of intrinsic value - what Zevra Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zevra Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Zevra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zevra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zevra Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.